Contents -- Contributing Authors -- Preface -- Acknowledgments -- I: Pathophysiology -- 1 Dystonia: Abnormal Movements Result from Loss of Inhibition -- 2 Sensory Deficits in Dystonia and Their Significance -- 3 Focal Hand Dystonia May Result from Aberrant Neuroplasticity -- 4 Basal Ganglia Neuronal Discharge in Primary and Secondary Dystonia -- 5 Evidence of Widespread Impairment of Motor Cortical Inhibition in Focal Dystonia: A Transcranial Magnetic Stimulation Study in -- 6 Modulation of Cortical Activity by Repetitive Transcranial Magnetic Stimulation (rTMS): A Review of Functional Imaging Studies -- II: Oppenheim's Dystonia -- 7 Dopamine Transmission in DYT1 Dystonia -- 8 Development and Anatomic Localization of TorsinA -- 9 Mouse Models of TorsinA Dysfunction -- 10 Dominant TorsinA Mutations in Cellular Systems -- 11 An Animal Model to Discern Torsin Function: Suppression of Protein Aggregation in -- 12 TorsinA and Early-Onset Torsion Dystonia -- 13 An Epidemiologic Survey of Dystonia Within the Entire Population of Northeast England Over the Past Nine Years -- III: Other Genetic Disorders -- 14 Dystonia Genotypes, Phenotypes, and Classification -- 15 Update on the Genetics of Primary Torsion Dystonia Loci -- and -- and the Dystonia-Plus Locus -- 16 Inherited Myoclonus-Dystonia -- 17 Penetrance and Expression of Dystonia Genes -- 18 Update on Dopa-Responsive Dystonia: Locus Heterogeneity and Biochemical Features -- 19 X-Linked Recessive Dystonia Parkinsonism (XDP -- Lubag -- DYT3) -- 20 Focal Dystonia Is Associated with a Polymorphism of the Dopamine D5 Receptor Gene -- 21 Dystonia With and Without Deafness Is Caused by TIMM8A Mutation -- IV: PET and Biochemistry of Dystonia -- 22 Abnormal Brain Networks in Primary Torsion Dystonia -- 23 Dysfunction of Dopaminergic Pathways in Dystonia.

24 Clinical Presentation and Progression of Sporadic and Familial Primary Torsion Dystonia in Italy -- 25 Cognition and Affect in Patients with Cervical Dystonia With and Without Tremor -- 26 Clinical Features of the -- in Cervical Dystonia -- 27 Executive Function in Dystonia -- 28 Duration of Effectiveness of Botulinum Toxin Type B in the Treatment of Cervical Dystonia -- 29 Is Phenotypic Variation of Hereditary Progressive Dystonia with Marked Diurnal Fluctuation/Dopa-Responsive Dystonia (HPD/DRD) -- V: Musicians' and Other Focal Dystonias -- 30 Focal Task-Specific Dystonia in Musicians -- 31 Brain Mapping in Musicians with Focal TaskSpecific Dystonia -- 32 Three-Dimensional Movement Analysis as a Promising Tool for Treatment Evaluation of Musicians' Dystonia -- 33 Limb Immobilization for Occupational Dystonia: A Possible Alternative Treatment for Selected Patients -- 34 Review of 113 Musicians with Focal Dystonia Seen Between 1985 and 2002 at a Clinic for Performing Artists -- 35 The Impact of Focal Dystonia on the Working Life of Musicians in the United Kingdom -- 36 Long-Term Outcome of Focal Dystonia in Instrumental Musicians -- 37 Abnormal Sensorimotor Processing in Pianists with Focal Dystonia -- VI: Therapeutics -- 38 Dystonia: Medical Therapy and Botulinum Toxin -- 39 Pallidotomy for Generalized Dystonia -- 40 Pallidal Stimulation for Dystonia -- 41 Off-Period Dystonia in Parkinson's Disease but Not Generalized Dystonia Is Improved By High-Frequency Stimulation of the Subt -- 42 Autonomic Side Effects of Botulinum Toxin Type B Therapy -- 43 Dystonia and Headaches: Clinical Features and Response to Botulinum Toxin Therapy -- 44 Rating Scales for Dystonia: Assessment of Reliability of Three Scales -- Subject Index.